期刊文献+

胰高血糖素瘤综合征1例 被引量:18

Glucagonoma syndrome :a case report
下载PDF
导出
摘要 报道1例46岁男性病人,全身皮肤红斑、水疱3年,加重1年,具有典型的坏死松解性游走性红斑,伴舌炎、糖尿病,体重下降,血胰高血糖素增高。皮肤组织病理变化为表皮浅层坏死,免疫组化发现表皮浅层抗人胰高血糖素抗体着色阳性。腹部CT及锝标记生长抑素类似物(Octreotide)扫描显示患者胰尾及肝脏肿瘤。长效生长抑素治疗后,血胰高血糖素水平在短期内明显下降,皮疹逐渐好转。 A46-year-old male presented with erythemas and blisters for three years that exacerbated for one year was re-ported.He had clinically characteristic necrolytic migratory erythema(NME),glossitis,diabetes mellitus,weight loss and hy-perglucagonemia.Skin biopsies showed necrosis of the superficial epidermis and immunohistochemical studies revealed glucagon deposition in the same areas.Computerized topography scanning and Octreotide radiography revealed multiple tu-mors in his pancreas tail and liver.After treatment with somatostatin analog,Lanreotide,the level of blood glucagon de-creased and the skin rash re covered gradually.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2002年第11期702-704,共3页 Journal of Clinical Dermatology
关键词 胰高血糖素瘤综合征 坏死松解性游走性红斑 生长抑素 内分泌肿瘤 CT 诊断 治疗 glucagonoma syndrome necrolytic migratory erythema lanreotide
  • 相关文献

参考文献4

  • 1Wermers RA, Fatourechi V, Wynne AG, et al. The glucagonoma syndrome. Clinical and pathologic features in 21 patients [J].Medicine, 1996, 75(2): 53-63.
  • 2Altimari AF, Bhoopalam N, O'Dorsio T, et al. Use of a somato statin analog (SMS 201-955) in the glucagonoma syndrome [J].Surgery, 1986, 100(6): 989-996.
  • 3Peterson LL, Shaw JC, Acott KM, et al. Glucagonoma syndrome: in vivo evidence that glucagons increases epidermal arachidonic acid[J]. J Am Acad Dermatol, 1984, 11(3): 468-473.
  • 4Kasper CS. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenisis. A case report and literature review[J]. Cutis, 1992, 49(2):120-128.

同被引文献131

引证文献18

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部